Patients with TTP may have a congenital deficiency or an acquired reduction in the synthesis of ADAMTS13, leading to platelet aggregation and the formation of intravascular thrombi. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.